Back to Search
GEORGE PLITAS, M.D.
M.D.
Surgical Oncology Physician
NPI: 1013179878IndividualAccepts Medicare
Education
NEW YORK UNIVERSITY SCHOOL OF MEDICINE
Class of 2002
Research & Publications (15)
Toll-like receptor 9 inhibition reduces mortality in polymicrobial sepsis.
PMID 18474631·J Exp Med·2008
7-preclinical
Dendritic cells are required for effective cross-presentation in the murine liver.
PMID 18213574·Hepatology·2008
7-preclinical
NK dendritic cells are innate immune responders to Listeria monocytogenes infection.
PMID 17371998·J Immunol·2007
7-preclinical
Experimental hindlimb ischemia increases neutrophil-mediated matrix metalloproteinase activity: a potential mechanism for lung injury after limb ischemia.
PMID 12742210·J Am Coll Surg·2003
7-preclinical
The lytic potential of human liver NK cells is restricted by their limited expression of inhibitory killer Ig-like receptors.
PMID 19587011·J Immunol·2009
4-observational
Vancomycin-resistant enterococci exploit antibiotic-induced innate immune deficits.
PMID 18724361·Nature·2008
7-preclinical
CD11c identifies a subset of murine liver natural killer cells that responds to adenoviral hepatitis.
PMID 18664530·J Leukoc Biol·2008
7-preclinical
Circulating HLA-DR(+) natural killer cells have potent lytic ability and weak antigen-presenting cell function.
PMID 18640163·Hum Immunol·2008
8-other
NK dendritic cells expanded in IL-15 exhibit antitumor responses in vivo.
PMID 17878363·J Immunol·2007
7-preclinical
Data courtesy of the U.S. National Library of Medicine (NLM). Ltrl is not affiliated with or endorsed by NLM.
Contact & Hours
- Address
- 300 E 66TH ST, EVELYN H. LAUDER BREAST CENTER
NEW YORK, NY 10065 - Phone
- (646) 888-4587
Quick Facts
- NPI
- 1013179878
- Entity Type
- Individual
- Gender
- Male
- Medicare
- Accepted
- Specialties
- 1
- Locations
- 1
- Years in Practice
- 24
- Publications
- 15
Are you this provider?
Claim Your Profile